Source Natural Foods and Herbal Supplements Ltd.
Snapshot View

View in App

Prices View details

161.90 +3.90 ▲2.5%

30 July 2021, 04:00:00 P.M.
Volume: 370

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.source_natural.com
Financial Indicators
Market Cap 104.15 Cr.
Earnings per share (EPS) 5.26 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) 30.73 Trailing Twelve Months Ending 2021-03
Industry PE 35.15 Trailing Twelve Months Ending 2021-03
Book Value / Share 20.45 Trailing Twelve Months Ending 2021-03
Price to Book Value 7.91 Calculated using Price: 161.80
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 0.64 Cr. 6,436,931 Shares
FaceValue 10
Company Profile

Inwinex Pharmaceuticals, incorporated in 1995, is engaged in the manufacture of pharmaceuticals. Earlier known as Inwinex Laboratories, it got its present name on March 2, 2007.

The company has been incurring losses for past couple of years on account of partial shutdown of the factory for renovation and inadequate working capital facilities. The factory, located at Hyderabad in Andhra Pradesh, has been completely shut down since April 12, 2006 due to inadequacy of working capital.

In 2000, company decided to hive-off the bulk drug unit and diversify into software related activities by changing the main clause. And in 2001, the company has signed an agreement with CDSL, NSDL and Venture Capital and Corporate Investment for dematerialization.

Business areas of the company:

The company manufactures antibiotics, norfloxacin, pefloxacin, enrofloxacin and electrolyte supplements.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
+2.47%
1 Week
+4.12%
1 Month
+6.65%
3 Month
+10.74%
6 Month
+14.62%
1 Year
+134.13%
2 Year
+118.78%
5 Year
+324.93%

Ratios View Details

9 years 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) -28.05 16.04 5.86 3.86 8.31 22.42 10.87 12.40 17.65
Return on Capital Employed (%) -16.98 8.19 3.56 3.22 8.94 20.40 11.67 13.56 20.89
Return on Assets (%) -15.35 7.53 3.30 2.75 6.76 15.73 7.31 9.84 14.60

Balance Sheet View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 2 2 5 5 6 7 8 9 10
Non Curr. Liab. 2 2 0 0 0 0 0 0 0
Curr. Liab. 0 0 0 1 1 4 3 2 3
Minority Int.
Equity & Liab. 4 5 6 6 7 11 11 10 12
Non Curr. Assets 3 4 4 4 3 4 4 4 4
Curr. Assets 1 1 2 2 3 8 7 6 9
Misc. Exp. not W/O 0
Total Assets 4 5 6 6 7 11 11 10 12

Profit Loss View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 2 4 5 7 11 16 11 13 14
Other Income 0 0 0 0 0 0
Total Income 2 4 5 7 11 16 11 13 14
Total Expenditure -2 -3 -4 -6 -10 -14 -9 -11 -11
PBIDT 0 1 0 1 1 2 1 2 2
Interest 0 0 0 0 0 0
Depreciation 0 0 0 -1 0 0 0 0 0
Taxation 0 0 0 0 0
Exceptional Items 0 0
PAT -1 0 0 0 0 1 1 1 2

Cash Flow View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 0 0 -1 0 3 0
Cash Fr. Inv. 0 0 -1 0 0 -2 0 0 -1
Cash Fr. Finan. 1 0 0 0 0 2 0 -2 0
Net Change 0 0 0 0 0 -1 0 1 -1
Cash & Cash Eqvt 0 1 0 1 1 0 0 1 0

Shareholding Pattern View Details

9 Qtrs 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%)
Promoter 74.37 74.37 74.37 74.37 74.37 74.37 74.37 74.37 74.37
Public 25.63 25.63 25.63 25.63 25.63 25.63 25.63 25.63 25.63
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Sat, 17 Jul 2021
Shareholding for the Period Ended June 30 2021
Source Natural Foods and Herbal Supplements Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30 2021. For more details kindly Click here
Fri, 16 Jul 2021
Format of Initial Disclosure to be made by an entity identified as a Large Corporate
Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1Name of CompaySOURCE NATURAL FOODS & HERBAL SUPPL LTD.
2CINL24231KA1995PLC101742
3 Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) 0.00
4Highest Credit Rating during the previous FY 0
4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable
5Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the frameworkBSE


We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No



Name of the Company Secretary: SWETA GAUR
Designation: Company Secretary
EmailId: cs@source-natural.com
Name of the Chief Financial Officer: Seshadri Ramaswamy
Designation: Chief Financial Officer
EmailId: cfo@source-natural.com

Date: 16/07/2021

Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
Wed, 14 Jul 2021
Record Date For Annual General Meeting
In compliance with Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements)
Regulation 2015 This is to inform that the Register of Members and Share Transfer Books
of the Company will remain closed from Thursday 29th July 2021 to Thursday 05th August 2021 (both days inclusive) for taking record of the Members for the purpose of 26th Annual General Meeting and the Record Date is Wednesday 28-07-2021

Technical Scans View Details

Fri, 30 Jul 2021
Stock Outperforming Benchmark Index in both 1 Week and 3 Month Stock Outperforming Benchmark Index in both 1 Week and 3 Month
Close Crossing Current Week High Close Crossing Current Week High
Closing Near 50 EMA Closing Near 50 EMA
Close Crossing 50 EMA From Below Close Crossing 50 EMA From Below
Close Crossing 20 EMA From Below Close Crossing 20 EMA From Below

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 185,708.53 774.00 +10.1%
Divi's Laboratories Ltd. 129,702.64 4,885.80 +0.8%
Dr. Reddy's Laboratories Ltd. 78,400.54 4,712.70 +0.9%
Cipla Ltd. 74,235.31 920.30 +4.3%
Cadila Healthcare Ltd. 59,986.20 585.95 +2.5%
Apollo Hospitals Enterprise Ltd. 57,873.32 4,025.00 -0.3%
Aurobindo Pharma Ltd. 53,701.27 916.50 +0.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 63.95 774.00 +10.1%
Divi's Laboratories Ltd. Consolidated 2021-03 65.36 4,885.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 45.13 4,712.70 +0.9%
Cipla Ltd. Consolidated 2021-03 30.87 920.30 +4.3%
Cadila Healthcare Ltd. Consolidated 2021-03 28.12 585.95 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 384.90 4,025.00 -0.3%
Aurobindo Pharma Ltd. Consolidated 2021-03 10.07 916.50 +0.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.00 774.00 +10.1%
Divi's Laboratories Ltd. Consolidated 2021-03 13.95 4,885.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 4.39 4,712.70 +0.9%
Cipla Ltd. Consolidated 2021-03 4.05 920.30 +4.3%
Cadila Healthcare Ltd. Consolidated 2021-03 4.62 585.95 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 12.60 4,025.00 -0.3%
Aurobindo Pharma Ltd. Consolidated 2021-03 2.45 916.50 +0.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 0.18 774.00 +10.1%
Divi's Laboratories Ltd. Consolidated 2020-03 0.00 4,885.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,712.70 +0.9%
Cipla Ltd. Consolidated 2020-03 0.18 920.30 +4.3%
Cadila Healthcare Ltd. Consolidated 2021-03 0.35 585.95 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 1.08 4,025.00 -0.3%
Aurobindo Pharma Ltd. Consolidated 2020-03 0.33 916.50 +0.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 9.66 774.00 +10.1%
Divi's Laboratories Ltd. Consolidated 2020-03 19.30 4,885.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,712.70 +0.9%
Cipla Ltd. Consolidated 2020-03 10.09 920.30 +4.3%
Cadila Healthcare Ltd. Consolidated 2021-03 18.30 585.95 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 13.08 4,025.00 -0.3%
Aurobindo Pharma Ltd. Consolidated 2020-03 18.53 916.50 +0.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 10.07 774.00 +10.1%
Divi's Laboratories Ltd. Consolidated 2020-03 25.36 4,885.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 15.24 4,712.70 +0.9%
Cipla Ltd. Consolidated 2020-03 12.53 920.30 +4.3%
Cadila Healthcare Ltd. Consolidated 2021-03 13.65 585.95 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 17.13 4,025.00 -0.3%
Aurobindo Pharma Ltd. Consolidated 2020-03 18.80 916.50 +0.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 32,837.50 774.00 +10.1%
Divi's Laboratories Ltd. Consolidated 2020-03 5,394.42 4,885.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,712.70 +0.9%
Cipla Ltd. Consolidated 2020-03 17,131.99 920.30 +4.3%
Cadila Healthcare Ltd. Consolidated 2021-03 15,102.20 585.95 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 11,246.80 4,025.00 -0.3%
Aurobindo Pharma Ltd. Consolidated 2020-03 23,098.51 916.50 +0.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 4,186.79 774.00 +10.1%
Divi's Laboratories Ltd. Consolidated 2020-03 1,376.54 4,885.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,712.70 +0.9%
Cipla Ltd. Consolidated 2020-03 1,546.98 920.30 +4.3%
Cadila Healthcare Ltd. Consolidated 2021-03 2,137.60 585.95 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 434.90 4,025.00 -0.3%
Aurobindo Pharma Ltd. Consolidated 2020-03 2,844.69 916.50 +0.9%